Zovighian Bernard J reported EW

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001225208-26-008780

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 9, 2026

Published

Nov 9, 2026

Ingested by INSIDER

Nov 10, 02:27 UTC

Last re-read

Nov 10, 02:27 UTC

Extracted facts

Filer

Zovighian Bernard J

Role

Director, CEO

Transaction

Option exerciseAs filed: “M”

Asset

Edwards Lifesciences Corp — Employee Stock Option (Right to Acquire)

Ticker

EW

Shares

23.1K

Price per share

$0

Execution date (reported)

Nov 9, 2026

Owned after transaction

23.1K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

0

What this establishes

Zovighian Bernard J filed this Form 4 reporting a option exercise of EW on Nov 9, 2026. It became public on Nov 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, CEO

Zovighian Bernard Jcik:0001665141

Issuer

Edwards Lifesciences Corpcik:0001099800

Revision history · 0

No field has changed since this record was first ingested.